Apollo Hospitals Enterprise Ltd (APOLLOHOSP) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Apollo Hospitals Enterprise Ltd on NSE and BSE, with an AI summary of each filing.
As per annexure enclosed
Intimation · 16 Oct 2026, 7:59 pm
Apollo Hospitals Schedules Institutional Investor Meetings in Singapore for Nov'26 Apollo Hospitals Enterprise Limited announced its participation in physical one-on-one and group institutional investor meetings in Singapore. The company will attend the BofA Securities 2026 India Corporate Day on 17th Nov'26 at OUE Bayfront, followed by Morgan Stanley’s 25th Annual Asia Pacific Summit on 18th–19th Nov'26 at Mandarin Oriental. No unpublished price-sensitive information will be shared.
As per annexure enclosed
Intimation · 05 Nov 2026, 3:00 pm
Apollo Hospitals Schedules Q2 FY27 Earnings Call for 5th Nov'26 Apollo Hospitals Enterprise Ltd. (AHEL) will announce its unaudited financial results for the quarter and half-year ended 30th Sep'26 on 4th Nov'26. Following the earnings release, the company will host an investor and analyst conference call on 5th Nov'26 at 3:00 PM IST. Senior management, including Managing Director Suneeta Reddy, Group CFO A. Krishnan, and segment leadership across the Hospitals Division, Apollo HealthCo, AHLL, and Pharmacy businesses, will represent AHEL to discuss operational performance and financial results.
APOLLO HOSPITALS ENTERPRISE LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 04 Nov 2026, 5:30 am
Apollo Hospitals Enterprise Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve As per annexure enclosed
Intimation · 04 Nov 2026, 5:30 am
Apollo Hospitals Schedules Board Meeting for Q2 FY27 Financial Results Apollo Hospitals Enterprise Limited has scheduled its Board of Directors meeting for 4th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Per insider trading regulations, the company's trading window remains closed for promoters, directors, connected persons, and designated employees from 1st Oct'26 until 6th Nov'26 (48 hours post-results announcement).
APOLLO HOSPITALS ENTERPRISE LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 04 Nov 2026, 5:30 am
To consider and approve the financial results for the period ended September 30, 2026 and other business matters
Financial Result · 12 Oct 2026, 5:25 pm
Apollo Hospitals Schedules Board Meeting for Q2 FY27 Financial Results Apollo Hospitals Enterprise Limited will hold a Board of Directors meeting on 4th Nov'26 to consider and approve standalone and consolidated unaudited financial results for the three and six months ended 30th Sep'26. In compliance with SEBI insider trading regulations, the company's trading window for promoters, directors, connected persons, and designated employees remains closed from 1st Oct'26 until 6th Nov'26 (48 hours post-results announcement).
as per annexure enclosed
Others (Uncategorized) · 03 Sept 2026, 11:30 pm
Apollo Hospitals Submits Newspaper Advertisements Regarding Share Transfer to IEPF Apollo Hospitals Enterprise Limited notified the BSE and NSE on 3rd Sep'26 about newspaper advertisements published in Business Standard and Makkal Kural. The notice pertains to the proposed transfer of equity shares to the Investor Education and Protection Fund (IEPF) pursuant to statutory provisions for consecutive unclaimed dividends. This regulatory compliance step ensures shareholders are publicly informed before their unclaimed shares are transferred to the government fund. Relevant details and verification procedures are also available on the company's official website for investor reference.
Dear Sir, Sub : Submission of Updated Annual Report for FY 2025-26 We refer to the Annual Report of the Company for the financial year ended 31 March 2026, which was submitted to the ....
Others (Uncategorized) · 28 Aug 2026, 8:55 pm
As per annexure enclosed
Annual General Meeting · 25 Aug 2026, 11:33 pm
Apollo Hospitals AGM: Shareholders Approve All Resolutions Including ₹7,500M Debenture Issue Apollo Hospitals Enterprise Limited announced that all 8 resolutions proposed at its 45th AGM on 25th Aug'26 were passed with the requisite majority. Key approvals include the adoption of FY26 financial statements and confirmation of dividends. Shareholders also passed a special resolution approving a private placement of non-convertible debentures aggregating up to ₹7,500 million. Other passed resolutions include the re-appointments of Dr. Prathap C Reddy as Executive Chairman and Smt. Sangita Reddy as Director, both of whom received over 96% of votes in favour.
As per annexure enclosed
Annual General Meeting · 25 Aug 2026, 11:24 pm
Apollo Hospitals AGM: Shareholders Approve All Resolutions, Including ₹750cr Fundraising At its 45th AGM on 25th Aug'26, Apollo Hospitals secured shareholder approval for all 8 resolutions. Key approvals include fundraising up to ₹7,500 million (₹750 crore) via private placement of non-convertible debentures and the adoption of FY26 financial statements. Shareholders also passed special resolutions for the re-appointment of Dr. Prathap C Reddy as Executive Chairman for two years and Ms. Rama Bijapurkar as an Independent Director for five years. All resolutions, including director re-appointments and dividend confirmation, received over 96% of votes in favor.
As per annexure enclosed
Annual General Meeting · 25 Aug 2026, 11:22 pm
Apollo Hospitals AGM: Shareholders Approve Debt Raise, Board Re-appointments Apollo Hospitals' shareholders approved all eight resolutions at its 45th AGM on 25th Aug'26. Key approvals include raising up to ₹7,500 million via non-convertible debentures on a private placement basis, which passed with 98.87% of votes. The re-appointment of Dr. Prathap C Reddy as Executive Chairman for two years was approved with 96.98% votes. Shareholders also approved the re-appointment of Smt. Sangita Reddy as Director (96.72% in favour) and confirmed dividends for FY26. All resolutions passed with a strong majority.
as per annexure enclosed
Transcript · 19 Aug 2026, 11:27 pm
Apollo Hospitals Q1FY27 Earnings Call Transcript Published Apollo Hospitals Enterprise Limited has released the transcript for its earnings call held on 13 Aug'26. The call discussed the unaudited financial results for the quarter ended 30 Jun'26 (Q1 FY27). This regulatory filing, dated 19 Aug'26, confirms the transcript's availability on the company's website, providing investors with detailed management commentary and analysis of the quarterly performance.
As per annexure enclosed
Audio / Video · 14 Aug 2026, 12:04 am
Apollo Hospitals: Audio Recording of Q1 FY27 Analyst Call Now Available Apollo Hospitals Enterprise Ltd has released the audio recording of its analyst call held on 13 Aug'26. The call discussed the company's financial results for the quarter ended 30 Jun'26. As per SEBI regulations, the recording is now accessible on the company's official website. This provides investors and analysts with direct insights into management's commentary on the quarterly performance and outlook. The link to the MP3 file has been provided in the stock exchange filing.
As per annexure enclosed
Investor Presentation · 13 Aug 2026, 3:22 am
Apollo Hospitals Q1FY27: Strong Growth Driven by Healthcare Services and Digital Apollo Hospitals reported strong Q1FY27 results with consolidated revenue up 21% YoY to ₹70,435 mio and PAT up 34% YoY to ₹5,805 mio. Growth was broad-based, led by a 22% revenue increase in Healthcare Services to ₹35,670 mio, with an EBITDA margin of 24.2%. The Apollo HealthCo segment grew 20% to ₹29,770 mio, driven by offline pharmacy and a narrowing digital cash loss. The AHLL segment (diagnostics) posted a 15% revenue increase and a 46% EBITDA jump, reflecting strong operational performance across all key verticals.
As per annexure enclosed
Intimation · 13 Aug 2026, 3:14 am
Apollo Hospitals Q1FY27: Strong Growth Across Segments Apollo Hospitals reported robust Q1FY27 results with consolidated revenue up 21% YoY to ₹70,435 mio and PAT up 34% YoY to ₹5,805 mio. The Healthcare Services segment was a key driver, with revenue growing 22% to ₹35,670 mio, supported by 13% volume growth and an 8% increase in average revenue per inpatient. The AHLL segment saw revenue climb 15%, driven by a 31% surge in Diagnostics. Apollo HealthCo revenue grew 20% YoY, with PAT increasing 78% to ₹1,013 mio and digital cash loss narrowing significantly.
As per annexure enclosec
Press Release · 13 Aug 2026, 1:57 am
Apollo Hospitals Reports Strong Q1FY27 with 21% YoY Revenue Growth Apollo Hospitals reported strong Q1FY27 results with consolidated revenue up 21% YoY to ₹7,043 Crore and PAT at ₹581 Crore. EBITDA grew 28% YoY to ₹1,092 Crore. The Healthcare Services segment was a key driver, with revenue up 22% YoY to ₹3,567 Crore and EBITDA up 20% to ₹862 Crore. The Apollo HealthCo segment also showed robust performance, with revenue growing 20% YoY to ₹2,977 Crore. The company continues its capacity expansion, aiming to add over 5,800 beds in the next five years.
As per annexure enclosed
Outcome · 13 Aug 2026, 1:35 am
Apollo Hospitals Reports Strong Q1FY27; Announces Strategic Corporate Actions Apollo Hospitals reported strong Q1FY27 results, with consolidated revenue up 21% YoY to ₹7,043 Crore and PAT at ₹581 Crore. EBITDA grew 28% YoY to ₹1,092 Crore. Healthcare Services revenue rose 22% YoY to ₹3,567 Crore, while Apollo HealthCo revenue increased 20% YoY to ₹2,977 Crore. The Board also approved the grant of 46,798 ESOPs/RSUs, the appointment of PwC as statutory auditors from FY28, and the slump sale of Apollo Healthco's FMCG/wellness wholesale business to a wholly-owned subsidiary, expected by 01 Oct'26.
As per annexure enclosed
Financial Result · 13 Aug 2026, 1:20 am
Apollo Hospitals Enterprise Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Million) ■ Revenue: 70,435 (+20.6% YoY | +6.6% QoQ) ■ EBITDA: 10,921 (+28.2% YoY | +8.0% QoQ) ■ EBITDA Margin (%): 15.5 (+92 bps YoY | +20 bps QoQ) ■ PAT: 5,807 (+34.2% YoY | +9.7% QoQ) ■ EPS (INR): 40.4 (+34.1% YoY | +9.8% QoQ) Apollo Hospitals Enterprise Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Million) Segmental Performance Healthcare services ■ Revenue: 36,195 (+21.7% YoY | +8.6% QoQ) ■ EBIT: 6,859 (+22.1% YoY | +11.6% QoQ) ■ EBIT Margin (%): 19.0 (+6 bps YoY | +51 bps QoQ) Retail health and diagnostics ■ Revenue: 4,995 (+14.8% YoY | +2.0% QoQ) ■ EBIT: 227 (+219.7% YoY | -43.1% QoQ) ■ EBIT Margin (%): 4.5 (+291 bps YoY | -361 bps QoQ) Digital health and pharmacy distribution ■ Revenue: 29,770 (+20.4% YoY | +4.5% QoQ) ■ EBIT: 1,523 (+120.1% YoY | +12.2% QoQ) ■ EBIT Margin (%): 5.1 (+232 bps YoY | +35 bps QoQ) Others ■ Revenue: 13.0 (+0.0% YoY | +0.0% QoQ) ■ EBIT: -39.0 (-290.0% YoY | -8.3% QoQ) ■ EBIT Margin (%): -300 (-22308 bps YoY | -2308 bps QoQ)
as per annexure enclosed
Annual General Meeting · 04 Aug 2026, 8:45 pm
Apollo Hospitals Announces 45th AGM and Final Dividend Details Apollo Hospitals Enterprise Ltd will hold its 45th AGM virtually on 25th Aug'26. The board has recommended a final dividend of Rs. 10 per equity share (200% of face value) for FY26. The record date to determine dividend eligibility is set for 14th Aug'26. The cut-off date for e-voting eligibility is 18th Aug'26. The remote e-voting window is open from 22nd Aug'26 to 24th Aug'26. The AGM notice and annual report are available on the company and stock exchange websites.
As per annexure enclosed
Annual General Meeting · 01 Aug 2026, 6:28 pm
As per annexure enclosed
Others (Uncategorized) · 01 Aug 2026, 6:20 pm
As per annexure enclosed
Intimation · 13 Aug 2026, 3:00 pm
Apollo Hospitals to Host Q1 FY27 Earnings Conference Call Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) will hold an analyst and investor conference call on 13th Aug'26 at 3:00 PM IST. The call will discuss the unaudited financial results for the quarter ending 30th Jun'26. The Q1 FY27 results are scheduled to be announced one day prior, on 12th Aug'26. Top management, including the Managing Director, Group CFO, and CEOs of the Hospitals, HealthCo, and Pharmacy divisions, will be present on the call to discuss performance and outlook.
Apollo Hospitals Enterprise Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve as per annexure enclosed
Intimation · 12 Aug 2026, 5:30 am
Apollo Hospitals to Announce Q1 FY27 Results on Aug 12, 2026 Apollo Hospitals Enterprise Ltd's board will meet on Wed, 12 Aug'26, to approve the unaudited standalone and consolidated financial results for the quarter ended 30 Jun'26. In compliance with SEBI regulations, the trading window for promoters, directors, and designated employees will remain closed from 01 Jul'26, until 48 hours after the results announcement, reopening on 15 Aug'26. This period, ending 14 Aug'26, prohibits trading by insiders. The meeting will also address other related corporate matters.
As per annexure enclosed
Others (Uncategorized) · 26 Jun 2026, 5:26 pm
As per annexure enclosed
Court Convened Meeting · 26 Jun 2026, 5:24 pm